Build a stronger evidence strategy with the data foundation needed to generate credible, decision-ready insights. For years, real-world evidence (RWE) was viewed primarily as a complement to randomized clinical trials or to provide post-market context. That perspective is changing. Regulators are increasingly recognizing the value of RWE, with expanded guidance and published examples demonstrating its power to inform regulatory outcomes across the product lifecycle, including in premarket applications. But RWE is only as strong as the data behind it. In today’s high-stakes, complex healthcare landscape, life sciences organizations need more than access to large volumes of data. They need a trusted, high-quality data foundation that enables rigorous analyses of drugs, devices, disease states, epidemiology, resource utilization, healthcare economics and clinical outcomes. Download Data is the Difference to learn: The characteristics of strong healthcare data and why they matter for credible RWE. Which types of data are most valuable. Common data challenges that can undermine evidence generation — and how to avoid them. How to help ensure data meets regulatory expectations for relevance and reliability.
